CapsoVision, Inc. Common Stock

CVNASDAQUSD
6.07 USD
0.30 (5.20%)AT CLOSE (11:59 AM EDT)
6.06
0.01 (0.17%)
POST MARKET (AS OF 05:29 PM EDT)
Post Market
AS OF 05:29 PM EDT
6.06
0.01 (0.17%)
🔴Market: CLOSED
Open?$5.80
High?$6.10
Low?$5.80
Prev. Close?$5.77
Volume?84.7K
Avg. Volume?411.1K
VWAP?$6.00
Rel. Volume?0.21x
Bid / Ask
Bid?$5.24 × 100
Ask?$6.95 × 100
Spread?$1.71
Midpoint?$6.10
Valuation & Ratios
Market Cap?302.5M
Shares Out?49.8M
Float?30.8M
Float %?65.7%
P/E Ratio?N/A
P/B Ratio?22.81
EPS?-$0.49
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.77Strong
Quick Ratio?3.09Strong
Cash Ratio?2.28Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUED
Score
50/100
P/E?
N/A
P/B?
22.81HIGH
P/S?
21.27HIGH
P/FCF?
N/A
EV/EBITDA?
-12.2CHEAP
EV/Sales?
20.56HIGH
Returns & Efficiency
ROE?
-185.4%WEAK
ROA?
-135.3%WEAK
Cash Flow & Enterprise
FCF?$-18771000
Enterprise Value?$292.4M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
Employees
99
Market Cap
302.5M
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed
2025-07-02
Address
18805 COX AVENUE SUITE 250
SARATOGA, CA 95070
Phone: (408) 370-4790